Large Animal/Histomorphometry
大型动物/组织形态计量学
基本信息
- 批准号:7750208
- 负责人:
- 金额:$ 28.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-14 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsArtsCanis familiarisCardiacCardiac OutputCharacteristicsChargeChronicCoronaryEnergy MetabolismEquipmentFinancial SupportFunctional disorderHeart failureHousingHumanHypertrophyLeadLicensingMeasurementMicrospheresMitochondriaModelingMusMyocardiumPeripheral ResistancePreparationProgram Research Project GrantsProtocols documentationResearch PersonnelResourcesServicesSpecimenTherapeutic EmbolizationTissue SampleTissuesTreatment ProtocolsVeterinariansanimal tissuedesignpressureresearch study
项目摘要
The objective of the Animal/Histomorphometry core is to provide investigators of the program project grant
(PPG) scientific, technical and financial support for the design and execution of studies involving animals and
histomorphometric assessment of cardiac tissue. Our state-of-the art facility houses and contains all the
animals and equipment necessary to execute experiments and analyze specimens from dogs with coronary
microembolization-induced heart failure (HF) as well as from dogs with rapid pacing-induced HF. Over the
past 23 years, we have developed and fully characterized a canine model of chronic HF which is ideally
suited for the studies outlined in the PPG. Heart failure in this model is produced by multiple sequential
intracoronary embolizations with microspheres that lead to loss of viable myocardium. The model manifests
many, if not all of the sequelae of HF in humans including profound systolic and diastolic LV dysfunction, LV
dilation and compensatory hypertrophy, increased LV filling pressures, increased systemic vascular
resistance, decreased cardiac output and, importantly, abnormalities of mitochondria and characteristic
progressive worsening of LV function. The Core will the perform the following aims: 1) coordinate the
acquisition, housing and preparation of dogs involved in the coronary microembolization-induced HF studies,
2) execute pharmacologic protocols involving coronary microembolization-induced HF i.e. assume
responsibility for treatment regimens for project 2, 3) coordinate distribution of dogs and cardiac tissues
derived from coronary microembolization-induced HF experiments and 4) perform histological analysis of
tissue samples derived from coronary-microembolization induced HF and mouse studies (Projects 1, 2 and
4) as well as from dogs with rapid-pacing-induced HF that are specific to project 3 of the PPG. Services to
PPG investigators will be provided by a team consisting of the Core Leader (Dr. H.N. Sabbah), the Core Co-
Leader (Dr. V.G. Sharov), 1 Assistant Staff Investigator (Dr M. Wang) and 1 Licensed Veterinary
Technologists (Ms. Annette Hazel). The facility veterinarian (Dr. Gregory Heisey) is an institutional resource
and will provide all the necessary and required veterinary support without charge.
动物/组织形态计量学核心的目的是提供计划项目赠款的调查员
(PPG)针对涉及动物的研究设计和执行的科学,技术和财政支持以及
心脏组织的组织形态计量学评估。我们最先进的设施房屋,并包含所有
执行实验和分析冠状动脉狗的标本所需的动物和设备
微栓塞引起的心力衰竭(HF)以及快速起搏引起的HF的狗。在
过去23年,我们已经开发并充分表征了慢性HF的犬模型,理想情况下是
适用于PPG中概述的研究。该模型中的心力衰竭是由多个顺序产生的
带有微球导致可行心肌丧失的冠状动脉内栓塞。该模型表现出来
许多人(如果不是全部)HF的后遗症,包括深度收缩和舒张期LV功能障碍,LV
扩张和补偿性肥大,LV填充压力增加,全身血管增加
电阻,心输出量降低,重要的是线粒体和特征性异常
LV功能的进行性恶化。核心将执行以下目的:1)协调
涉及冠状动脉微栓塞引起的HF研究的狗的获取,住房和制备,
2)执行涉及冠状动脉微栓塞诱导的HF的药理方案,即假设
项目2的治疗方案的责任2,3)协调狗和心脏组织的分布
源自冠状动脉微栓塞引起的HF实验,4)进行组织学分析
衍生自冠状动脉微栓塞诱导的HF和小鼠研究的组织样品(项目1、2和
4)以及来自PPG项目3的快速诱导的HF的狗。服务
PPG调查人员将由由核心负责人(H.N. Sabbah博士)组成的团队提供
负责人(V.G. Sharov博士),1名助理参谋长(M. Wang博士)和1名许可的兽医
技术人员(Annette Hazel女士)。设施兽医(Gregory Heisey博士)是一种机构资源
并将在不指控的情况下提供所有必要和必要的兽医支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HANI N SABBAH其他文献
HANI N SABBAH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HANI N SABBAH', 18)}}的其他基金
Rate Control and Cardiac Energitics in heart Failure
心力衰竭中的心率控制和心脏能量
- 批准号:
7750202 - 财政年份:2009
- 资助金额:
$ 28.67万 - 项目类别:
Fatty Acid Oxidation in Heart Failure Progression
心力衰竭进展中的脂肪酸氧化
- 批准号:
7000634 - 财政年份:2004
- 资助金额:
$ 28.67万 - 项目类别:
相似国自然基金
青藏高原“中更新世”岩面艺术的热释光年代学研究
- 批准号:42371161
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
艺术品高光谱成像数字典藏与光谱颜色再现研究
- 批准号:62275025
- 批准年份:2022
- 资助金额:59 万元
- 项目类别:面上项目
科学与艺术的邂逅:艺术对科技创新的启示
- 批准号:
- 批准年份:2022
- 资助金额:10 万元
- 项目类别:
基于音色与颜色关联的艺术视听感知计算方法研究
- 批准号:62276240
- 批准年份:2022
- 资助金额:53.00 万元
- 项目类别:面上项目
为无价之物定价:基于大数据方法的艺术品市场定价机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)
人类 iPSC 神经元、小胶质细胞和星形胶质细胞的神经回路、动力学和能量 HTS:用于目标 ID、药物发现和毒性(例如癌症化疗)的 AI 平台
- 批准号:
10707866 - 财政年份:2023
- 资助金额:
$ 28.67万 - 项目类别:
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
人类首例 SAD
- 批准号:
10061521 - 财政年份:2019
- 资助金额:
$ 28.67万 - 项目类别:
Aspheric SDOCT Imaging System for Dry Eye and Cornea Diagnostics
用于干眼和角膜诊断的非球面 SDOCT 成像系统
- 批准号:
8394731 - 财政年份:2012
- 资助金额:
$ 28.67万 - 项目类别:
Optogenetic Control of Vigilance State Transition
警戒状态转变的光遗传学控制
- 批准号:
7985497 - 财政年份:2010
- 资助金额:
$ 28.67万 - 项目类别: